An injection that can prevent HIV infection for six months has been approved by the US Food and Drug Administration (FDA).

Ever wish that you could make your dog's life longer? While crossing the rainbow bridge is part of a dog's short life, ...

Talk to a healthcare professional about whether a supplement is the right fit for your individual health, and about any ...

The Food and Drug Administration has approved Harliku (nitisinone) for the reduction of urine homogentisic acid in adult patients with alkaptonuria.

Canalevia® (crofelemer delayed-release tablets), under the name Canalevia-CA1, is conditionally approved by the FDA for ...

But this medication has not been formally approved by the Food and Drug Administration — and research has raised concerns about its potential cancer risk, Bloomberg reported. 3 AZO works by ...

The approval was based on two phase 1 crossover studies, which compared zanubrutinib tablets with the capsule formulation in healthy adult participants.

BeOne Medicines Ltd. (NASDAQ: ONC; HKEX: 06160; SSE: 688235), a global oncology company, today announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency ...

The FDA didn’t routinely test the medications for quality problems or use its vast repository of drug-related complaints to ...

Ozempic is an FDA-approved medication for people with type 2 diabetes. It’s often prescribed off-label for weight loss — that ...

Phathom gains FDA exclusivity for VOQUEZNA through 2032, boosting stock. DCF values shares at $14 with 43% upside potential.

The recent commercial re-launch of LIKMEZ® (ATI-1501), following new patent coverage through to 2039, marked a major milestone for Appili and our partner, Saptalis Pharmaceuticals, LLC (“Saptalis”).